Alan Hulme

Alan Hulme

Director/Board Member at Oncopeptides Incentive AB

Net worth: 121 380 $ as of 2024-04-29

Health Technology
Commercial Services
Electronic Technology

Profile

Alan Hulme is currently a Director at Oncopeptides Incentive AB and Techgen Corporate Development Ltd.
He previously served as Chairman at Oncopeptides AB from 2010 to 2018.
He also held positions as Chairman at Techgen International Ltd., Director at Quiatech AB, Mesophotonics Ltd., OLIGOvation AB, Principal at IDEXX Laboratories, Inc., and Principal at Affymetrix, Inc.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2023-08-28 457,813 ( 0.22% ) 121 380 $ 2024-04-29

Alan Hulme active positions

CompaniesPositionStart
Oncopeptides Incentive AB Director/Board Member -
Techgen Corporate Development Ltd. Director/Board Member -
All active positions of Alan Hulme

Former positions of Alan Hulme

CompaniesPositionEnd
ONCOPEPTIDES AB Chairman 2018-05-16
Director/Board Member 2007-08-29
Chairman -
Director/Board Member -
Director/Board Member -
See the detail of Alan Hulme's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Alan Hulme's experience

Connections

22

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies2
IDEXX LABORATORIES, INC.

Health Technology

ONCOPEPTIDES AB

Health Technology

Private companies7

Health Technology

Health Technology

Electronic Technology

Commercial Services

Commercial Services

Oncopeptides Incentive AB

Techgen Corporate Development Ltd.

See company connections